Skip to content
S6759Senate2017-2018 Session

Add Drugs to Controlled List

Official title

“Relates to adding substances to the various schedules of controlled substances”

Sponsor Kemp HannonSD-6Affects Health
Status
In Senate Committee
Health
Impact
6/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill adds various new substances to New York's controlled substances schedules, updating and expanding the list of regulated drugs.

Why it matters

  1. Statewide reach. The changes would apply across New York, affecting people and businesses handling the named substances. They would take effect 90 days after becoming law.

  2. Beyond new drug names. The bill would broaden Schedule IV’s “other substances” provision to cover isomers and salts of isomers where possible, not just the listed substances and their salts. That would extend the provision’s reach to additional chemical forms.

  3. Different schedule placements. Perampanel would enter Schedule III, alfaxalone and suvorexant Schedule IV, and brivaracetam Schedule V. The bill would also correct “Ibogane” to “Ibogaine” in Schedule I rather than add a separate entry.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Who cares

  • Pharmacists and prescribers

    The bill would place named drugs, including perampanel, suvorexant and brivaracetam, in specific state controlled-substance schedules.

  • Drug manufacturers and distributors

    Companies handling listed substances would need to account for their proposed schedule placements and the expanded coverage of chemical forms in Schedule IV.

  • Law enforcement and prosecutors

    The bill would add explicit Schedule I entries for substances including AH-7921, acetyl fentanyl and a-PVP.

  • Patients using the named drugs

    The proposed scheduling of perampanel, suvorexant and brivaracetam would bring those drugs within the specified state controlled-substance categories.

Headline styles

Add Drugs to Controlled List

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Kemp Hannon

Senator · Senate District 6

Chair, Health

No co-sponsors yet.

History

  1. Referred to health
  2. Returned to senate
  3. Died in assembly
  4. Referred to health
  5. Delivered to assembly
  6. Passed senateVote 63–0
  7. Ordered to third reading cal.2106
  8. Referred to rules

Full text

3 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

6759

2017-2018 Regular Sessions

IN SENATE

June 16, 2017

Introduced by Sen. HANNON -- read twice and ordered printed, and when printed to be committed to the Committee on Rules

AN ACT to amend the public health law, in relation to adding substances to the schedules of controlled substances

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivision (b) of schedule I of section 3306 of the public health law is amended by adding two new paragraphs 56 and 57 to read as follows:

(56) 3,4-dichloro-N-{(1-dimethylamino)cyclohexylmethyl}benzamide. Some trade or other names: AH-7921.

(57) N-(1-phenethylpiperidin-4-yl)-N-phenlyacetamide (Acetyl Fentanyl).

§ 2. Paragraph 11 of subdivision (d) of schedule I of section 3306 of the public health law, as added by chapter 664 of the laws of 1985, is amended to read as follows:

(11) [Ibogane] Ibogaine Some trade and other names: 7-ethyl-6, 6&, 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5h-pyrido {1',2':1,2} azepino {5,4-b} indole: tabernanthe iboga.

§ 3. Subdivision (d) of schedule I of section 3306 of the public health law is amended by adding thirty-four new paragraphs 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68 and 69 to read as follows:

(36) 5-methoxy-N,N-dimethyltryptamine.

(37) Alpha-methyltryptamine. Some trade or other names: AMT.

(38) 5-methoxy-N,N-diisopropyltryptamine. Some trade or other names: 5-MeO-DIPT.

(39) 5-(1,1-dimethylheptyl)-2-{(1R,3S)-3-hydroxycyclohexyl}-phenol. Some trade or other names: CP-47,497.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD13230-01-7

S. 6759 2

(40) 5-(1,1-dimethyloctyl)-2-{(1R,3S)-3-hydroxycyclohexyl}-phenol. Some trade or other names: cannabicyclohexanol or CP-47,497 C8-homolog.

(41) 1-butyl-3-(1-naphthoyl)indole. Some trade or other names: JWH-073.

(42) 1-hexyl-3-(1-naphthoyl)indole. Some trade or other names: JWH-019.

(43) 1-{2-(4-morpholinyl)ethyl}-3-(1-naphthoyl)indole. Some trade or other names: JWH-200.

(44) 1-pentyl-3-(2-methoxyphenylacetyl)indole. Some trade or other names: JWH-250.

(45) 1-pentyl-3-{1-(4-methoxynaphthoyl)}indole. Some trade or other names: JWH-081.

(46) 1-pentyl-3-(4-methyl-1-naphthoyl)indole. Some trade or other names: JWH-122.

(47) 1-pentyl-3-(4-chloro-1-naphthoyl)indole. Some trade or other names: JWH-398.

(48) 1-(5-fluoropentyl)-3-(1-naphthoyl)indole. Some trade or other names: AM2201.

(49) 1-(5-fluoropentyl)-3-(2-iodobenzoyl)indole. Some trade or other names: AM694.

(50) 1-pentyl-3-{(4-methoxy)-benzoyl}indole. Some trade or other names: SR-19 and RCS-4.

(51) 1-cyclohexylethyl-3-(2-methoxyphenylacetyl)indole. Some trade or other names: SR-18 and RCS-8.

(52) 1-pentyl-3-(2-chlorophenylacetyl)indole. Some trade or other names: JWH-203.

(53) (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl) methanone. Some trade or other names: UR-144.

(54) {1-(5-fluoro-pentyl)-1H-indol-3-yl}(2,2,3,3-tetramethylcyclopropyl) methanone. Some trade or other names: 5-fluoro-UR-144,XLR11.

(55) N-(1-adamantyl)-1-pently-1H-indazole-3-carboxamide. Some trade or other names: APINACA, AKB 48.

(56) quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate. Some trade or other names: PB-22 and QUPIC.

(57) quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate. Some trade or other names: 5-fluoro-PB-22 and 5F-PB-22.

(58) N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide. Some trade or other names: AB-FUBINACA.

(59) N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3- carboxamide. Some trade or other names: ADB-PINACA.

(60) 4-methyl-N-ethylcathinone. Some trade or other names: 4-MEC.

(61) 4-methyl-alpha-pyrrolidinopropiophenone. Some trade or other names: 4-MePPP.

(62) alpha-pyrrolidinopentiophenone. Some trade or other names: a-PVP.

(63) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butan-1-one. Some trade or other names: butylone and bk-MBDB.

(64) 2-(methylamino)-1-phenylpentan-1-one. Some trade or other names: pentedrone.

(65) 1-(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1- one. Some trade or other names: pentylone and bk-MBDP.

(66) 4-fluoro-N-methylcathinone. Some trade or other names: 4-FMC and flephedrone.

(67) 3-fluoro-N-methylcathinone. Some trade or other names: 3-FMC.

(68) 1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one. Some trade or other names: naphyrone.

S. 6759 3

(69) alpha-pyrrolidinobutiophenone. Some trade or other names: a-PBP.

§ 4. Subdivision (h) of schedule II of section 3306 of the public health law is amended by adding two new paragraphs 64 and 65 to read as follows:

(64) Methasterone (2{alpha}17{alpha}-dimethyl-5{alpha}-androstan- 17{beta}-ol-3-one).

(65) Prostanozol (17{beta}-hydroxy-5{alpha}-androstano{3,2-c}pyrazole).

§ 5. Subdivision (c) of schedule III of section 3306 of the public health law is amended by adding a new paragraph 15 to read as follows:

(15) Perampanel.

§ 6. Subdivision (c) of schedule IV of section 3306 of the public health law is amended by adding two new paragraphs 54 and 55 to read as follows:

(54) Alfaxalone.

(55) Suvorexant.

§ 7. Subdivision (f) of schedule IV of section 3306 of the public health law, as added by chapter 664 of the laws of 1985, paragraph 2 as added by chapter 457 of the laws of 2006 and paragraph 3 as added by section 14 of part C of chapter 447 of the laws of 2012, is amended to read as follows:

(f) Other substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts, isomers, and salts, of such isomers, whenever the existence of such salts, isomers, and salts of isomers is possible:

(1) Pentazocine.

(2) Butorphanol (including its optical isomers).

(3) Tramadol in any quantities.

(4) Lorcaserin.

(5) Eluxadoline.

§ 8. Subdivision (d) of schedule V of section 3306 of the public health law is amended by adding a new paragraph 4 to read as follows:

(4) Brivaracetam.

§ 9. This act shall take effect on the ninetieth day after it shall have become a law.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law, in relation to adding substances to the schedules of controlled substances

Purpose

This bill would update the State controlled substances schedules, promoting consistency with the federal schedules and promoting health and safety.

Summary of provisions

Section 1 of the bill would add a synthetic opioid analgesic; often known as AH-7921, and one fentanyl analog, Acetytl Fentanyl, to Schedule I (b) of Public Health Law (PHL) § 3306.

Section 2 of the bill would amend PHL § 3306, Schedule I (d) to correct the spelling of ibogane to ibogaine.

Section 3 of the bill would add a number of substances to PHL § 3306, Schedule I (d).

Section 4 of the bill would amend PHL § 3306, Schedule II (h) to add methasterone and prostanozol.

Section 5 of the bill would amend PHL § 3306, Schedule III (c) to add perampanel.

Section 6 of the bill would amend PHL § 3306, Schedule IV (c) to add alfaxalone and suvorexant.

Section 7 of the bill would amend PHL § 3306, Schedule IV (f) to clarify that the inclusion of salts and isomers applies whenever such salts or isomers are possible within the specific chemical designation of a substance. The section also would add lorcaserin and eluxadoline to Schedule IV (f).

Section 8 of the bill would amend PHL § 3306, Schedule V (d) to add brivaracetam. Section 9 would set forth the effective date.

Justification

This bill would update the New York State controlled substances schedules to conform to the current federal schedules of controlled substances. Individuals often exploit the fact that certain drugs classified as controlled substances under federal law are not similarly classified as controlled substances under New York law, and thus are more easily diverted. Consistency between the State and federal schedules is therefore important to address the prevalence of abuse and misuse of controlled substances.

The bill would also add other known dangerous substances to the State schedule of controlled substances, including a synthetic opioid analgesic, often is known as AH-7921, which can cause a psychoactive reaction and has led to a number of deaths within the United States and other counties. Additionally, the bill would clarify that the inclusion of salts and isomers applies whenever such salts or isomers are possible within the specific chemical designation of a substance.

Legislative history

New bill.

Fiscal implications

None.

Effective date

90 days, succeeding enactment.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.